520P Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer with and without liver metastasis: A subgroup analysis of the phase III FRESCO-2 trial.

Authors :: Garcia-Carbonero, R.
Dasari, N.A.
Eng, C.
Tabernero, J.
Yoshino, T.
Hochster, H.
Arnold, D.
Randrian, V.
Schelman, W.
Dong, L.
Yu, Z.
Chen, L.
Lonardi, S.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS439-S439. 1p.
Publication Year :: 2024

Subjects :: *COLORECTAL liver metastasis
*CLINICAL trials
*METASTASIS
*PATIENT safety
*SUBGROUP analysis (Experimental design)

Full Text Access

Tools